Food and Drug Administration Drug Approval Process: A History and Overview.

Area of Science:

• Pharmaceutical Sciences
• Regulatory Affairs
• Health Economics

Background:

• Overview of investigational and new drug application processes.
• Examination of standard and expedited review pathways.
• Contextualization within US healthcare policy, including insurance coverage and prescription drug sales.

Observation:

• The US Food and Drug Administration (FDA) is enhancing transparency and oversight in drug development.
• High costs of new drug development necessitate efficient processes.
• Increased prescription drug sales and decreased uninsured adults are noted economic factors.

Findings:

• Detailed description of investigational and new drug application processing.
• Analysis of standard versus expedited regulatory review timelines and criteria.
• Review of FDA initiatives for improved agency transparency and fiscal responsibility.

Implications:

• Streamlined and cost-effective drug approval processes are crucial for safe and timely drug delivery.
• Enhanced FDA oversight aims to balance drug innovation with public safety.
• Understanding regulatory pathways is vital for pharmaceutical companies and healthcare stakeholders.